NanoTemper Boston User Meeting: Pushing the Boundaries of Biophysical Characterization
RegisterWhat you can expect
-
A talk from Stefan Duhr, NanoTemper CEO
A forward-looking talk on where biophysical characterization is headed, including emerging market trends and cutting-edge research directions.
-
Guided breakout sessions
Exchange workflow tips with fellow attendees and members of our Application Team in focused breakout discussions on Prometheus Panta, Monolith, and Dianthus.
-
Panel discussion
An open conversation with our esteemed guest speakers and leading voices of the NanoTemper Team.
-
Monolith Omni showcase
A show-and-tell featuring NanoTemper's newly launched Monolith Omni, a platform for in-solution binding kinetics that requires no immobilization and minimal sample consumption.
-
User talks & case studies
Hear directly from researchers using NanoTemper's technologies in their work.
-
Lunch & networking
Dedicated time to connect with fellow users and the NanoTemper team over lunch and posters.
-
10:00 AM – 10:20 AM
Arrival: Check-in, coffee, pastries, and casual networking
-
10:20 AM – 10:30 AM
Welcome address: Opening remarks from CEO Stefan Duhr, Ph.D.
-
10:30 AM – 10:55 AM
Talk by Ishrat Jalal, Ph.D., Senior Scientist - Biophysics Assay and Screening, WuXi AppTec on ultra-high-throughput screening with Dianthus uHTS and Spectral Shift
-
10:55 AM – 11:20 AM
Talk by Alice Ma, Ph.D., Scientific Account Manager at Cube Biotech on membrane protein purification and stability characterization with Prometheus Panta
-
11:20 AM – 11:30 AM
Short morning break and first free raffle drawing: $50 Uber Eats gift card
-
11:30 AM – 12:00 PM
Breakout discussions: Workflow tips guided by NanoTemper's Application Team members, divided into groups for binding affinity and protein stability.
-
12:00 PM – 01:05 PM
Complimentary lunch, casual networking, and posters (For lunch, we will have an option: Vegetarian/Vegan/Gluten Free. All food will be labelled with their ingredients)
-
01:05 PM – 01:30 PM
Talk by Hossam Nada, Ph.D., Assistant Professor of Pharmaceutical Science at University of Massachusetts Lowell on Monolith and automated AI/ML agents for drug discovery
-
01:30 PM – 01:50 PM
Talk by Stefan Duhr, Ph.D., CEO and Co-Founder of NanoTemper Technologies on future directions in biophysical characterization
-
01:50 PM – 02:00 PM
Short afternoon break and second free raffle drawing: $100 Best Buy gift card
-
02:00 PM – 02:20 PM
Talk by Nathan Wallace, PhD: “Introduction to Monolith Omni” — Overview on the technology behind Monolith Omni: binding, kinetics, and stability in one workflow
-
02:20 PM – 02:40 PM
Omni show & tell — Sample experiment and data analysis
-
02:40 PM – 03:00 PM
Panel discussion and audience Q&A — NanoTemper Team and guest speakers
-
03:00 PM
Closing remarks and and final free raffle drawing: Exclusive NanoTemper Training Session
Speaker information
Senior Scientist - Biophysics Assay and Screening, WuXi AppTec
Ishrat is a Senior Scientist with the Biophysics team at WuXi AppTec’s Natick, MA site, supporting early drug discovery efforts through biophysical assay development, screening, and hit validation. She uses both SPR and SpS/MST platforms primarily to characterize small-molecule binding. As a NanoTemper alumna who still has a warm spot for the technology, she previously supported Monolith, Dianthus, and Prometheus Panta as an Application Scientist. She earned her Ph.D. in Biochemistry at the University of Calgary in Alberta, Canada, where she used solution NMR to characterize protein-ligand interactions within the Structural Biology Research Group.
Field Application Scientist Manager, NanoTemper Technologies
With seven years of experience in biotech, Nathan Wallace is a Field Applications Scientist Manager at NanoTemper Technologies. He holds a PhD in Biology and is passionate about supporting cutting-edge drug discovery research through innovative biophysical characterization solutions. Outside of work, he enjoys spending time outdoors with his wife and dog.
CEO and Co-Founder, NanoTemper Technologies
Stefan Duhr co-founded NanoTemper Technologies in 2008, guided by a belief that complex biophysical science should be accessible, actionable, and built alongside the scientists who use it. He holds an M.Sc. in Biochemistry from Universität Witten/Herdecke and a doctorate in Physics from Ludwig-Maximilians-Universität München. Today, he leads NanoTemper’s mission to co-create tools that help drug developers move from data to confident decisions, faster.
Assistant Professor of Pharmaceutical Science, University of Massachusetts Lowell
Hossam Nada is a computational drug discovery researcher at UMass Lowell, working at the intersection of structural biology, cheminformatics, and biophysical validation. His research focuses on developing practical computational approaches for challenging drug discovery problems, including structure-guided ligand design, fragment-based screening, and the identification and optimization of small-molecule binders. He is a co-author of LigandForge, a web-based platform designed to support synthesis-aware de novo ligand generation and lead optimization.
Scientific Account Manager, Cube Biotech
Alice Ma is a Scientific Account Manager at Cube Biotech, bringing a PhD in Biochemistry and expertise in protein chemistry, structural biology, and antibody discovery to help biotech and pharma teams solve complex protein challenges. She's passionate about enabling great science through trusted, scientist-to-scientist partnerships. Outside of work, she's an avid long-distance runner and boxer.